1 Mackman N. The many faces of tissue factor. J Thromb Haemost 2009; 7(Suppl 1): 136–9. 2 Mackman N. Tissue-specific hemostasis in mice. Arterioscler Thromb Vasc Biol 2005; 25: 2273–81. 3 Gregory SA, Morrissey JH, Edgington TS. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol 1989; 9: 2752–5. 4 Osterud B. Tissue factor expression in blood cells. Thromb Res 2010; 125(Suppl 1): S31–4. 5 Osterud B, Flaegstad T. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis. Thromb Haemost 1983; 49: 5–7. 6 Mackman N, Brand K, Edgington TS. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. J Exp Med 1991; 174: 1517–26. 7 Mackman N. Regulation of the tissue factor gene. FASEB J 1995; 9: 883–9. 8 Hall AJ, Vos HL, Bertina RM. Lipopolysaccharide induction of tissue factor in THP-1 cells involves Jun protein phosphorylation and nuclear factor kappaB nuclear translocation. J Biol Chem 1999; 274: 376–83. 9 GuhaM, O Connell MA, Pawlinski R, Hollis A,McGovern P, Yan SF, Stern D, Mackman N. Lipopolysaccharide activation of the MEKERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 2001; 98: 1429–39. 10 van den EijndenMM, Steenhauer SI, Reitsma PH, Bertina RM. Tissue factor expression duringmonocyte-macrophage differentiation.Thromb Haemost 1997; 77: 1129–36. 11 Ahamed J, Niessen F, Kurokawa T, Lee YK, Bhattacharjee G, Morrissey JH, Ruf W. Regulation of macrophage procoagulant responses by the tissue factor cytoplasmic domain in endotoxemia. Blood 2007; 109: 5251–9. 12 Pawlinski R,Wang JG, Owens AP 3rd,Williams J, Antoniak S, Tencati M, Luther T, Rowley JW, Low EN, Weyrich AS, Mackman N. Hematopoietic and nonhematopoietic cell tissue factor activates the coagulation cascade in endotoxemic mice. Blood 2010; 116: 806–14. 13 Del Conde I, Shrimpton CN, Thiagarajan P, Lopez JA. Tissue-factorbearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 2005; 106: 1604–11. 14 Wang JG, Williams JC, Davis BK, Jacobson K, Doerschuk CM, Ting JP, Mackman N. Monocytic microparticles activate endothelial cells in an IL-1beta-dependent manner. Blood 2011; 118: 2366–74. 15 Owens AP 3rd, Mackman N. Microparticles in hemostasis and thrombosis. Circ Res 2011; 108: 1284–97. 16 Owens AP 3rd, Passam FH, Antoniak S, Marshall SM, McDaniel AL, Rudel L, Williams JC, Hubbard BK, Dutton JA, Wang J, Tobias PS, Curtiss LK, Daugherty A, Kirchhofer D, Luyendyk JP, Moriarty PM, Nagarajan S, Furie BC, Furie B, Johns DG, et al. Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin. J Clin Invest 2012; 122: 558–68. 17 Furlan-Freguia C, Marchese P, Gruber A, Ruggeri ZM, Ruf W. P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice. J Clin Invest 2011; 121: 2932–44. 18 Wang JG, Manly D, Kirchhofer D, Pawlinski R, Mackman N. Levels of microparticle tissue factor activity correlate with coagulation activation in endotoxemic mice. J Thromb Haemost 2009; 7: 1092–8. 19 Aras O, Shet A, Bach RR, Hysjulien JL, Slungaard A, Hebbel RP, Escolar G, Jilma B, Key NS. Induction of microparticleand cellassociated intravascular tissue factor in human endotoxemia. Blood 2004; 103: 4545–53. 20 Baroni M, Pizzirani C, Pinotti M, Ferrari D, Adinolfi E, Calzavarini S, Caruso P, Bernardi F, Di Virgilio F. Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. FASEB J 2007; 21: 1926–33. 21 Rao LV, Kothari H, Pendurthi UR. Tissue factor encryption and decryption: facts and controversies. Thromb Res 2012; 129(Suppl 2): S13–7. 22 Solle M, Labasi J, Perregaux DG, Stam E, Petrushova N, Koller BH, Griffiths RJ, Gabel CA. Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem 2001; 276: 125–32.
[1]
V. Sharma,et al.
More on: optimal dose for stroke thrombolysis in Asians
,
2012,
Journal of thrombosis and haemostasis : JTH.
[2]
D. Kirchhofer,et al.
Tissue factor promotes activation of coagulation and inflammation in a mouse model of sickle cell disease.
,
2012,
Blood.
[3]
M. Sun,et al.
Optimal dose for stroke thrombolysis in Asians: low dose may have similar safety and efficacy as standard dose
,
2012,
Journal of thrombosis and haemostasis : JTH.
[4]
N. Key,et al.
Tissue factor n positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysis
,
2022
.
[5]
K. Ataga,et al.
Association of Coagulation Activation with Clinical Complications in Sickle Cell Disease
,
2012,
PloS one.
[6]
S. G. Betal,et al.
Heme induces endothelial tissue factor expression: potential role in hemostatic activation in patients with hemolytic anemia
,
2008,
Journal of thrombosis and haemostasis : JTH.
[7]
S. Saad,et al.
Increased adhesive properties of neutrophils in sickle cell disease may be reversed by pharmacological nitric oxide donation
,
2008,
Haematologica.
[8]
P. Stein,et al.
Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease.
,
2006,
The American journal of medicine.
[9]
E. Raz,et al.
TLR9-based immunotherapy for allergic disease.
,
2006,
The American journal of medicine.
[10]
C. Pegelow,et al.
Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment.
,
2003,
JAMA.
[11]
M. Gladwin,et al.
Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease
,
2002,
British journal of haematology.
[12]
C. Moertel,et al.
Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease.
,
1998,
Blood.
[13]
R. Hebbel,et al.
Tissue factor expression by endothelial cells in sickle cell anemia.
,
1998,
The Journal of clinical investigation.
[14]
J. Hofrichter,et al.
A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy.
,
1996,
Blood.